Walgreens Boots Alliance Inc (WBA) Shares Bought by Tocqueville Asset Management L.P.

Tocqueville Asset Management L.P. grew its stake in Walgreens Boots Alliance Inc (NASDAQ:WBA) by 1.4% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 18,393 shares of the pharmacy operator’s stock after purchasing an additional 246 shares during the period. Tocqueville Asset Management L.P.’s holdings in Walgreens Boots Alliance were worth $1,257,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Doyle Wealth Management bought a new position in shares of Walgreens Boots Alliance during the 4th quarter worth about $178,000. Robeco Institutional Asset Management B.V. lifted its holdings in shares of Walgreens Boots Alliance by 7.0% during the 4th quarter. Robeco Institutional Asset Management B.V. now owns 630,566 shares of the pharmacy operator’s stock worth $43,071,000 after acquiring an additional 41,335 shares during the period. New York State Common Retirement Fund lifted its holdings in shares of Walgreens Boots Alliance by 10.4% during the 4th quarter. New York State Common Retirement Fund now owns 2,327,550 shares of the pharmacy operator’s stock worth $159,041,000 after acquiring an additional 218,700 shares during the period. Seizert Capital Partners LLC bought a new position in shares of Walgreens Boots Alliance during the 4th quarter worth about $239,000. Finally, Bbva Compass Bancshares Inc. lifted its holdings in shares of Walgreens Boots Alliance by 4.5% during the 4th quarter. Bbva Compass Bancshares Inc. now owns 19,173 shares of the pharmacy operator’s stock worth $1,310,000 after acquiring an additional 817 shares during the period. Institutional investors own 63.55% of the company’s stock.

WBA stock traded down $4.58 during trading on Friday, hitting $66.61. 10,290,416 shares of the stock traded hands, compared to its average volume of 4,704,869. Walgreens Boots Alliance Inc has a one year low of $59.07 and a one year high of $86.31. The company has a market capitalization of $66.45 billion, a P/E ratio of 11.36, a P/E/G ratio of 1.10 and a beta of 0.98. The company has a quick ratio of 0.36, a current ratio of 0.80 and a debt-to-equity ratio of 0.44.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings results on Thursday, December 20th. The pharmacy operator reported $1.46 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.43 by $0.03. Walgreens Boots Alliance had a net margin of 3.96% and a return on equity of 22.17%. The firm had revenue of $33.79 billion during the quarter, compared to the consensus estimate of $33.90 billion. During the same period last year, the firm posted $1.28 EPS. The firm’s quarterly revenue was up 9.9% on a year-over-year basis. As a group, research analysts expect that Walgreens Boots Alliance Inc will post 6.52 earnings per share for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 12th. Shareholders of record on Friday, February 15th will be given a $0.44 dividend. This represents a $1.76 annualized dividend and a yield of 2.64%. The ex-dividend date is Thursday, February 14th. Walgreens Boots Alliance’s payout ratio is presently 29.24%.

A number of equities analysts have recently commented on WBA shares. Zacks Investment Research downgraded shares of Walgreens Boots Alliance from a “buy” rating to a “hold” rating in a report on Monday, November 26th. Morgan Stanley raised their price objective on shares of Walgreens Boots Alliance from $55.00 to $77.00 and gave the stock an “equal weight” rating in a report on Monday, December 3rd. Goldman Sachs Group downgraded shares of Walgreens Boots Alliance from a “neutral” rating to a “sell” rating in a report on Friday, December 14th. BidaskClub downgraded shares of Walgreens Boots Alliance from a “strong-buy” rating to a “buy” rating in a report on Tuesday, December 18th. Finally, Wolfe Research reaffirmed a “peer perform” rating on shares of Walgreens Boots Alliance in a report on Wednesday, December 19th. Five equities research analysts have rated the stock with a sell rating, eleven have given a hold rating and five have given a buy rating to the company’s stock. Walgreens Boots Alliance presently has an average rating of “Hold” and an average price target of $78.67.

ILLEGAL ACTIVITY NOTICE: This report was published by Markets Daily and is the property of of Markets Daily. If you are accessing this report on another domain, it was stolen and republished in violation of U.S. & international trademark and copyright laws. The original version of this report can be read at https://www.themarketsdaily.com/2019/03/03/walgreens-boots-alliance-inc-wba-shares-bought-by-tocqueville-asset-management-l-p.html.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.

Recommended Story: Special Dividends

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply